EN-US Fri, 24 May 2013 05:17:19 -0400 238402 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nTIR7oEKhFE/omeros-oms721-files-for-orphan-drug-status-analyst-blog-cm238402 Investing Business Stocks Omeros Corporation ( OMER ) recently announced that the company has filed an Application for Orphan Drug Designation with the US Food and Drug Administration (FDA) for its candidate OMS721.<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/nTIR7oEKhFE" height="1" width="1"/> Fri, 19 Apr 2013 01:11:07 Z 2013-04-18T22:16:08Z Zacks Equity Research ALXN ATHX OMER VRX http://www.nasdaq.com/article/omeros-oms721-files-for-orphan-drug-status-analyst-blog-cm238402 231994 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/POAbjrDF9Qg/omeros-progresses-with-oms824-analyst-blog-cm231994 Investing Business Stocks Omeros Corporation ( OMER ) recently announced positive results from the multiple-ascending-dose (MAD) section of the company's phase I study on OMS824. We note that OMS824 is the lead<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/POAbjrDF9Qg" height="1" width="1"/> Fri, 29 Mar 2013 03:26:44 Z 2013-03-29T00:28:00Z Zacks Equity Research CYTK NVS OMER PFE http://www.nasdaq.com/article/omeros-progresses-with-oms824-analyst-blog-cm231994 210113 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_ZsxrWyk644/safety-data-on-omeros-oms302-analyst-blog-cm210113 Investing Business Stocks Omeros Corporation ( OMER ) recently announced that it successfully completed the 90-day safety database lock for the second of its two phase III studies on OMS302. OMS302 is being<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/_ZsxrWyk644" height="1" width="1"/> Thu, 24 Jan 2013 03:14:14 Z 2013-01-23T23:20:56Z Zacks Equity Research BAYRY OMER REGN TRGT http://www.nasdaq.com/article/safety-data-on-omeros-oms302-analyst-blog-cm210113 203619 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s2m9VH8KUBE/mixed-trial-results-from-omeros-analyst-blog-cm203619 Investing Business Stocks Omeros Corporation ( OMER ) recently reported mixed results from its first pivotal phase III study that was being conducted with OMS103HP in patients undergoing arthroscopic partial<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/s2m9VH8KUBE" height="1" width="1"/> Thu, 03 Jan 2013 04:05:01 Z 2013-01-03T01:00:49Z Zacks Equity Research OMER TZYM http://www.nasdaq.com/article/mixed-trial-results-from-omeros-analyst-blog-cm203619 192487 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DiaMG9mdmW0/bearish-macd-for-omeros-corp-tale-of-the-tape-cm192487 Investing Investing Ideas Stocks Omeros Corp. 's ( OMER ) MACD indicator has moved into bearish territory with a reading of -0.8503. The Zacks #4 Rank ("Sell") stock decreased more than 1.53% to $7.07 in morning<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/DiaMG9mdmW0" height="1" width="1"/> Fri, 23 Nov 2012 20:29:01 Z 2012-11-23T17:39:55Z Zacks Equity Research OMER http://www.nasdaq.com/article/bearish-macd-for-omeros-corp-tale-of-the-tape-cm192487 151470 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FTce7GTjAvo/premarket-most-active-for-jun-27-2012-eric-amrn-bac-fb-abb-jnj-tkc-nok-omer-arna-nvo-znga-cm151470 News Headlines Pre-market Most Active The NASDAQ 100 Pre-Market Indicator is up 2.52 to 2,552.36. The total Pre-Market volume is currently 4,904,234 shares traded. The following are the most active stocks for the pre-market<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/FTce7GTjAvo" height="1" width="1"/> Wed, 27 Jun 2012 16:39:53 Z 2012-06-27T13:01:02Z NASDAQ.com News ABB AMRN ARNA BAC ERIC FB JNJ NOK NVO OMER TKC ZNGA http://www.nasdaq.com/article/premarket-most-active-for-jun-27-2012-eric-amrn-bac-fb-abb-jnj-tkc-nok-omer-arna-nvo-znga-cm151470